Dina Spencer is Community Manager & Digital Editor at PharmaBoardroom. She lives in Madrid and is interested in all things international.
Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital, Stockholm, is a rising star in life sciences innovation. The Stockholm region…
Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and Boehringer Ingelheim conducting more and more of their global…
Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In light of this epidemic,…
In a potentially significant step forward in biopharmaceutical supply chain logistics, a collaboration between AT&T, Direct Relief, MSD and Softbox is testing the potential of drones to deliver temperature-dependent medicines…
Under Thailand’s Universal Coverage Scheme, Thai citizens at every stage of life are entitled to essential health services and 99% of its population are currently covered. This year, not resting…
Spanish plasma specialist Grifols is making a move to invest in Africa, and was recently selected as the supplier for Soludia Maghreb’s new plant in Morocco. The CEOs of both…
China’s rapidly-growing biotech sector is increasingly hungry for preclinical drug candidates to commercialise in China, and Chinese companies are spending top dollar for cutting-edge technology from the US and UK.…
Sweden, home of IKEA, Pippi Longstocking and Abba, is one of Europe’s most innovative and forward-thinking nations in the healthcare and life sciences sphere. Here are five top facts to…
Egypt has seen a decade of great transformation, from political instability and uncertainty to its current relative stability. Healthcare reform now stands near the top of the government’s agenda and…
PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart some of their career progressions since then. …
With a strong research base formed around the Karolinska Institute and Uppsala University, Sweden has grown to be one of Europe’s premier biotech hotspots. Several companies spun out of research…
Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal will give Pfizer…
See our Cookie Privacy Policy Here
